Shree Ganesh Remedies Past Earnings Performance
Past criteria checks 6/6
Shree Ganesh Remedies has been growing earnings at an average annual rate of 23.1%, while the Pharmaceuticals industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 20.6% per year. Shree Ganesh Remedies's return on equity is 22.1%, and it has net margins of 18.7%.
Key information
23.1%
Earnings growth rate
22.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 20.6% |
| Return on equity | 22.1% |
| Net Margin | 18.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Shree Ganesh Remedies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,174 | 220 | 82 | 0 |
| 30 Sep 23 | 1,115 | 215 | 78 | 0 |
| 30 Jun 23 | 993 | 189 | 61 | 0 |
| 31 Mar 23 | 902 | 170 | 70 | 0 |
| 31 Dec 22 | 815 | 150 | 74 | 0 |
| 30 Sep 22 | 806 | 148 | 71 | 0 |
| 30 Jun 22 | 763 | 139 | 51 | 0 |
| 31 Mar 22 | 713 | 134 | 48 | 0 |
| 31 Dec 21 | 661 | 126 | 78 | 0 |
| 30 Sep 21 | 582 | 112 | 76 | 0 |
| 30 Jun 21 | 515 | 101 | 74 | 0 |
| 31 Mar 21 | 491 | 98 | 73 | 0 |
| 31 Dec 20 | 499 | 94 | 56 | 0 |
| 30 Sep 20 | 529 | 92 | 74 | 0 |
| 30 Jun 20 | 588 | 99 | 71 | 0 |
| 31 Mar 20 | 648 | 105 | 69 | 0 |
| 31 Dec 19 | 572 | 95 | 55 | 0 |
| 30 Sep 19 | 497 | 86 | 40 | 0 |
| 30 Jun 19 | 425 | 74 | 38 | 0 |
| 31 Mar 19 | 353 | 62 | 37 | 0 |
| 31 Dec 18 | 352 | 56 | 35 | 0 |
| 30 Sep 18 | 350 | 49 | 33 | 0 |
| 30 Jun 18 | 312 | 48 | 35 | 0 |
| 31 Mar 18 | 273 | 47 | 36 | 0 |
| 31 Mar 17 | 199 | 26 | 26 | 0 |
| 31 Mar 16 | 155 | 11 | 24 | 0 |
| 31 Mar 15 | 165 | 13 | 24 | 0 |
| 31 Mar 14 | 183 | 32 | 23 | 0 |
Quality Earnings: 540737 has high quality earnings.
Growing Profit Margin: 540737's current net profit margins (18.7%) are higher than last year (18.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 540737's earnings have grown significantly by 23.1% per year over the past 5 years.
Accelerating Growth: 540737's earnings growth over the past year (46.6%) exceeds its 5-year average (23.1% per year).
Earnings vs Industry: 540737 earnings growth over the past year (46.6%) exceeded the Pharmaceuticals industry 23.8%.
Return on Equity
High ROE: 540737's Return on Equity (22.1%) is considered high.